Yehuda Reznick's most recent trade in Oramed Pharmaceuticals, Inc was a trade of 30,000 Common Stock done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc | Yehuda Reznick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 30,000 | 60,560 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Yehuda Reznick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 8,370 | 68,930 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Yehuda Reznick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 760 | 30,560 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals Inc | Yehuda Reznick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2024 | 29,800 | 29,800 (0%) | 0% | - | Common Stock |